BridgeBio Pharma Inc (BBIO)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$34.15
Buy
$35.00
$0.67 (+2.00%)
Prices updated at 23 Apr 2025, 00:39 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | 98.25 | -260.19 | -241.44 | -196.86 | -437m |
| 2023 | 73.71 | -6,443.56 | -6,913.92 | -6,078.34 | -565m |
| 2022 | 95.58 | -603.28 | -619.70 | -511.85 | -397m |
| 2021 | 95.53 | -827.12 | -806.90 | -765.73 | -534m |
| 2020 | 100.00 | -5,751.99 | -5,439.74 | -5,665.86 | -467m |
| 2019 | 93.84 | -656.41 | -642.47 | -687.77 | -279m |
| 2018 | - | - | - | - | -167m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | 28.10 | - | - |
| 2024 | 22.98 | - | - |
| 2023 | 670.16 | - | - |
| 2022 | 12.59 | - | - |
| 2021 | 40.35 | - | - |
| 2020 | 381.39 | - | - |
| 2019 | 153.83 | - | - |
Price/Forward earnings (YTD)
-8.69
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | -73.11 | - | - |
| 2023 | -110.00 | - | - |
| 2022 | -58.83 | - | - |
| 2021 | -65.55 | - | - |
| 2020 | -67.21 | -192.44 | -78.57 |
| 2019 | -47.53 | -72.05 | -59.96 |
| 2018 | -46.45 | -101.80 | -71.17 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| 2020 | 12.15 |
| 2019 | 1.55 |
| 2018 | 1.48 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
